Late detection of critical congenital heart disease among us infants stimation of the potential impact of proposed universal screening using pulse oximetry

JAMA Pediatrics

Volumn 168, Issue 4, 2014, Pages 361-370

  Peterson, Cora ^a,b   Ailes, Elizabeth ^a,c   Riehle Colarusso, Tiffany ^a   Oster, Matthew E ^a,d   Olney, Richard S ^a   Cassell, Cynthia H ^a   Fixler, David E ^e   Carmichael, Suzan L ^f   Shaw, Gary M ^f   Gilboa, Suzanne M ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA ARCH ANOMALY; AORTA COARCTATION; AORTA VALVE STENOSIS; ARTERIAL TRUNK; ARTICLE; AUTOPSY; CHILDBIRTH; CONGENITAL HEART DISEASE; CRITICAL CONGENITAL HEART DISEASE; CRITICALLY ILL PATIENT; DELIVERY; EBSTEIN ANOMALY; ECHOCARDIOGRAPHY; FALLOT TETRALOGY; GREAT VESSELS TRANSPOSITION; HEART RIGHT VENTRICLE DOUBLE OUTLET; HEART SINGLE VENTRICLE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; NEWBORN SCREENING; PREVALENCE; PRIORITY JOURNAL; PULMONARY VALVE ATRESIA; PULMONARY VALVE STENOSIS; PULSE OXIMETRY; UNITED STATES;

HEART DEFECTS, CONGENITAL; HUMANS; INFANT; MASS SCREENING; OXIMETRY; PREVALENCE; UNITED STATES;

EID: 84898426506     PISSN: 21686203     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapediatrics.2013.4779     Document Type: Article

References (51)

1. Mahle WT, Newburger JW, Matherne GP, et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Interdisciplinary Council on Quality of Care and Outcomes Research; American Academy of Pediatrics Section on Cardiology and Cardiac Surgery, and Committee on Fetus and Newborn. Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation. 2009;120(5):447-458.
2. Thangaratinam S, Daniels J, Ewer AK, Zamora J, Khan KS. Accuracy of pulse oximetry in screening for congenital heart disease in asymptomatic newborns: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2007;92(3):F176-F180.
3. Kemper AR, MahleWT, Martin GR, et al. Strategies for implementing screening for critical congenital heart disease. Pediatrics. 2011;128(5):e1259-e1267.
4. Ewer AK. Review of pulse oximetry screening for critical congenital heart defects in newborn infants. Curr Opin Cardiol. 2013;28(2):92-96.
5. Discretionary Advisory Committee on Heritable Disorders in Newborns and Children. HHS Secretary adopts recommendation to add critical congenital heart disease to the recommended uniform screening panel. http://www.hrsa.gov/ advisorycommittees/mchbadvisory/heritabledisorders/index.html. Published 2011. Accessed November 1, 2011.
6. Centers for Disease Control and Prevention. Rapid implementation of pulse oximetry newborn screening to detect critical congenital heart defects: New Jersey, 2011. MMWR Morb Mortal Wkly Rep. 2013;62(15):292-294.
7. Centers for Disease Control and Prevention. Assessment of current practices and feasibility of routine screening for critical congenital heart defects: Georgia, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(15):288-291.
8. Hoke TR, Donohue PK, Bawa PK, et al. Oxygen saturation as a screening test for critical congenital heart disease: a preliminary study. Pediatr Cardiol. 2002;23(4):403-409.
9. Reich JD,Miller S, Brogdon B, et al. The use of pulse oximetry to detect congenital heart disease. J Pediatr. 2003;142(3):268-272.
10. Reich JD, Connolly B, Bradley G, et al. The reliability of a single pulse oximetry reading as a screening test for congenital heart disease in otherwise asymptomatic newborn infants. Pediatr Cardiol. 2008;29(5):885-889.
11. Schultz AH, Localio AR, Clark BJ, Ravishankar C, Videon N, Kimmel SE. Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics. 2008;121(4):751-757.
12. Bradshaw EA, Cuzzi S, Kiernan SC, Nagel N, Becker JA, Martin GR. Feasibility of implementing pulse oximetry screening for congenital heart disease in a community hospital. J Perinatol. 2012;32(9):710-715.
13. WalshW. Evaluation of pulse oximetry screening in Middle Tennessee: cases for consideration before universal screening. J Perinatol. 2011;31(2):125-129.
14. Abu-HarbM, Hey E,Wren C. Death in infancy from unrecognised congenital heart disease. Arch Dis Child. 1994;71(1):3-7.
15. Wren C, Richmond S, Donaldson L. Presentation of congenital heart disease in infancy: implications for routine examination. Arch Dis Child Fetal Neonatal Ed. 1999;80(1):F49-F53.
16. Bakr AF, Habib HS. Combining pulse oximetry and clinical examination in screening for congenital heart disease. Pediatr Cardiol. 2005;26(6): 832-835.
17. Rosati E, Chitano G, Dipaola L, De Felice C, Latini G. Indications and limitations for a neonatal pulse oximetry screening of critical congenital heart disease. J Perinat Med. 2005;33(5):455-457.
18. Arlettaz R, Bauschatz AS, MönkhoffM, Essers B, Bauersfeld U. The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatr. 2006;165(2):94-98.
19. Brown KL, Ridout DA, Hoskote A, Verhulst L, Ricci M, Bull C. Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart. 2006;92(9):1298-1302.
20. Mellander M, Sunnegardh J. Failure to diagnose critical heart malformations in newborns before discharge: an increasing problem? Acta Paediatr. 2006;95(4):407-413.
21. Ruangritnamchai C, BunjapamaiW, Pongpanich B. Pulse oximetry screening for clinically unrecognized critical congenital heart disease in the newborns. Images Paediatr Cardiol. 2007;9(1):10-15.
22. Meberg A, Brügmann-Pieper S, Due R Jr, et al. First day of life pulse oximetry screening to detect congenital heart defects. J Pediatr. 2008;152(6):761-765.
23. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed. 2008;93(1):F33-F35.
24. de-Wahl Granelli A,Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;338:a3037. doi:10.1136/bmj.a3037.
25. Meberg A, Andreassen A, Brunvand L, et al. Pulse oximetry screening as a complementary strategy to detect critical congenital heart defects. Acta Paediatr. 2009;98(4):682-686.
26. Ewer AK, Middleton LJ, Furmston AT, et al; PulseOx Study Group. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 2011;378(9793):785-794.
27. Turska Kmie? A, Borszewska Kornacka MK, Ba W, KawalecW, Zuk M. Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: experience of the POLKARD pulse oximetry programme 2006-2008 in Poland. Kardiol Pol. 2012;70(4):370-376.
28. Garg LF, Van Naarden Braun K, Knapp MM, et al. Results from the New Jersey Statewide critical congenital heart defects screening program. Pediatrics. 2013;132(2):e314-e323. doi:10.1542/peds.2013-0269.
29. Peterson C, Dawson A, Grosse SD, et al. Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection? Birth Defects Res A Clin Mol Teratol. 2013;97(10):664-672.
30. Ng B, Hokanson J. Missed congenital heart disease in neonates. Congenit Heart Dis. 2010;5(3):292-296.
31. Oster ME, Lee KA, HoneinMA, Colarusso T, Shin M, Correa A. Temporal trends in survival among infants with critical congenital heart defects. Pediatrics. 2013;131(5):e1502-e1508. doi:10.1542/peds.2012-3435.
32. Aamir T, Kruse L, Ezeakudo O. Delayed diagnosis of critical congenital cardiovascular malformations (CCVM) and pulse oximetry screening of newborns. Acta Paediatr. 2007;96(8):1146-1149.
33. Chang RK, Gurvitz M, Rodriguez S. Missed diagnosis of critical congenital heart disease. Arch Pediatr Adolesc Med. 2008;162(10):969-974.
34. Koppel RI, Druschel CM, Carter T, et al. Effectiveness of pulse oximetry screening for congenital heart disease in asymptomatic newborns. Pediatrics. 2003;111(3):451-455.
35. Kuehl KS, Loffredo CA, Ferencz C. Failure to diagnose congenital heart disease in infancy. Pediatrics. 1999;103(4, pt 1):743-747.
36. Frohnert BK, Lussky RC, Alms MA, Mendelsohn NJ, Symonik DM, Falken MC. Validity of hospital discharge data for identifying infants with cardiac defects. J Perinatol. 2005;25(11):737-742.
37. Strickland MJ, Riehle-Colarusso TJ, Jacobs JP, et al. The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young. 2008;18(suppl 2): 92-100.
38. Yoon PW, Rasmussen SA, Lynberg MC, et al. The National Birth Defects Prevention Study. Public Health Rep. 2001;116(suppl 1):32-40.
39. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A; National Birth Defects Prevention Study. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007;79(10):714-727.
40. Rasmussen SA, Olney RS, Holmes LB, Lin AE, Keppler-Noreuil KM, Moore CA; National Birth Defects Prevention Study. Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol. 2003;67(3):193-201.
41. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706.
42. Lee J, Tan CS, Chia KS. A practical guide for multivariate analysis of dichotomous outcomes. Ann Acad Med Singapore. 2009;38(8):714-719.
43. Prudhoe S, Abu-Harb M, Richmond S, Wren C. Neonatal screening for critical cardiovascular anomalies using pulse oximetry. Arch Dis Child Fetal Neonatal Ed. 2013;98(4):F346-F350.
44. Lurie IW, Kappetein AP, Loffredo CA, Ferencz C. Non-cardiac malformations in individuals with outflow tract defects of the heart: the Baltimore-Washington Infant Study (1981-1989). Am J Med Genet. 1995;59(1):76-84.
45. Oyen N, Poulsen G, Boyd HA,Wohlfahrt J, Jensen PK, Melbye M. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J. 2009;157(3):467-473.e1. doi:10.1016/j.ahj.2008.
46. Ingaramo OA, Khemani RG, Markovitz BP, Epstein D. Effect of race on the timing of the Glenn and Fontan procedures for single-ventricle congenital heart disease. Pediatr Crit Care Med. 2012;13(2):174-177.
47. Nembhard WN, Salemi JL, Ethen MK, Fixler DE, Dimaggio A, Canfield MA. Racial/ethnic disparities in risk of early childhood mortality among children with congenital heart defects. Pediatrics. 2011;127(5):e1128-e1138. doi:10.1542/peds .2010-2702.
48. Kogon B, Jain A, OsterM,Woodall K, Kanter K, Kirshbom P. Risk factors associated with readmission after pediatric cardiothoracic surgery. Ann Thorac Surg. 2012;94(3):865-873.
49. Fixler DE, Nembhard WN, Xu P, Ethen MK, Canfield MA. Effect of acculturation and distance from cardiac center on congenital heart disease mortality. Pediatrics. 2012;129(6):1118-1124.
50. MahleWT, Martin GR, Beekman RH III, Morrow WR; Section on Cardiology and Cardiac Surgery Executive Committee. Endorsement of Health and Human Services recommendation for pulse oximetry screening for critical congenital heart disease. Pediatrics. 2012;129(1):190-192.
51. Olney RS, Botto L. Newborn screening for critical congenital heart disease: essential public health roles for birth defects monitoring programs. Birth Defects Res A Clin Mol Teratol. 2012;94(12):965-969.